Manufacturing issues are common with regenerative medicines. And so it goes for PolarityTE’s investigational new drug submission for SkinTE. On Tuesday the Salt Lake Salt Lake City biotech revealed that it has put its investigational new drug (IND) application on hold in chronic cutaneous ulcers to address chemistry, manufacturing and control (CMC) issues raised by the agency. The […]

Shoreline Biosciences, an immunotherapy company formed in 2020 during the early days of the COVID-19 pandemic, was propelled into the proverbial catbird’s seat this summer with two mega-deals, and now plans to double its employee base from 50 to 100 in the coming six to nine months. Shoreline Biosciences is developing an off-the-shelf, targeted, allogeneic […]

The capabilities of the biotech industry are stretching further than previously thought possible. Thanks to research, manufacturing capabilities, and other forms of innovation, cell therapies that were once an aspiration for the distant future are now a reality. The promise of cell therapies lies in the fact that they are essentially living drugs working in […]